Medical Oncology ESMO

Related by string. * Medi Cal . MEDICAL . medicals . medical . MediCal : County Medical Examiner . Veterans Affairs Medical . medical examiner office . Medical Examiner Office / ONCOLOGY . oncology : Radiation Oncology ASTRO . pediatric oncology . oncology virology inflammation . oncology indications / Esmod . ESMOD : ECCO ESMO . Esmod Dubai . University Esmod . ESMO Accepted Abstract * *

Related by context. All words. (Click for frequent words.) 78 League Against Rheumatism 77 Cardiology ESC 77 Liver EASL 76 ESMO 76 Clinical Oncology Annual Meeting 75 Infectious Diseases ECCMID 75 Hematology ASH Annual Meeting 75 Clinical Microbiology 75 Hematology Annual Meeting 73 Cardiology ESC Congress 73 Diabetes EASD 73 Multiple Sclerosis ECTRIMS 73 ERA EDTA 73 European CanCer Organisation ECCO 72 Hematology Meeting 72 Urology EAU 72 Cardiology Heart Failure 71 Respiratory Society 71 ECCO ESMO 71 Hypertension ESH 71 Radiology ECR 71 Gastrointestinal Cancer 70 EULAR Annual 69 Nephrology Renal Week 69 Cancers Symposium 69 Rheumatology EULAR 69 ECTRIMS 69 Clinical Oncology ASCO Annual 69 Hematology ASH 69 Association EHA 68 ASH Annual Meeting 68 UEGW 68 Epileptology 68 Therapeutic Radiology 68 Connective Tissue Oncology 68 Clinical Oncology ASCO 67 ISPOR 67 Hematology 67 Neurological Societies 67 Hematology ASH Meeting 67 Annual Scientific Sessions 66 Hypertension ASH 65 Medical Oncology 65 Retina Specialists 65 Clinical Oncology Gastrointestinal Cancers 65 Interventional Radiology SIR 65 Venereology EADV 65 Radiation Oncology ASTRO 65 Advanced Neuroendocrine Tumors 65 annual Transcatheter Cardiovascular 65 st Annual Meeting 65 ASCO GI 65 Haemostasis ISTH 65 AACR San Antonio 65 Malignant Lymphoma 65 Oncology ESTRO 64 EULAR 64 Therapeutics TCT scientific 64 International OARSI 64 Percutaneous Cardiovascular Interventions 64 Nephrology Annual Meeting 64 European CanCer Organisation 64 Neurological Societies EFNS 64 Therapeutic Radiation 64 Clinical Oncologists 63 Genitourinary Cancers Symposium 63 nd Annual Meeting 63 Chemotherapy ICAAC 63 CTRC AACR San Antonio 63 Microbiology ASM 63 Hyperthermic Oncology ESHO 63 International Cartilage Repair 63 ASCO Annual Meeting 63 Breast Surgeons ASBS 63 Cancer iSBTc 62 Gastrointestinal Cancers Symposium 62 Neuro Oncology SNO 62 Clinical Oncology ASCO Gastrointestinal 62 AACR #st Annual Meeting 62 Therapeutics TCT 62 EORTC NCI AACR 62 EORTC NCI AACR Symposium 62 Annual Transcatheter Cardiovascular 62 Society CTOS 62 Molecular Targets 62 EFNS 62 Allergology 62 ECCMID 62 Nephrology ASN Renal 62 Biological Therapy 62 Paediatric Oncology SIOP 62 Symposium SABCS 62 Digestive Disease Week DDW 62 Clinical Oncology 62 Venereology 61 Minimally Invasive Gynecology 61 Diabetes EASD Annual Meeting 61 ECNP 61 Infectious Disease ECCMID 61 Scientific Sessions 61 Digestive Disease Week 61 Related Disorders ICAD 61 AACR #nd Annual Meeting 61 Endocrine Society ENDO 61 Gene Therapy ASGT 61 Endourology 61 Cardiostim 61 Mineral Research ASBMR 61 EADV 61 Pharmacoeconomics 61 International Myeloma Workshop 61 Antimicrobial Agents 61 International Papillomavirus 61 Embryology ESHRE 60 Experimental Biology Annual Meeting 60 Paediatric Infectious Diseases 60 Immunodeficiencies 60 Clinical Immunology EAACI 60 PROactive Study 60 EASL 60 Hyperthermic Oncology 60 Human Genetics ASHG 60 Stem Cell Research ISSCR 60 Gastroenterology Week UEGW 60 Neuropathic Pain 60 EuroPCR 60 Movement Disorder 60 Transcatheter Cardiovascular Therapeutics TCT 60 TG MV 60 Liver Diseases AASLD 60 ICAAC 60 Neurological Surgeons CNS 60 EORTC NCI 59 Cellular Therapy ISCT 59 Refractive Surgeons ESCRS 59 Neuropsychopharmacology ECNP 59 AUA Annual Meeting 59 Pharmaceutical Scientists AAPS 59 Retina Specialists ASRS 59 Thrombosis 59 Oncology ASTRO 59 San Antonio Breast Cancer 59 #st Annual Meeting 59 #th Annual Interscience 59 Nephrology ASN 59 Mass Spectrometry ASMS 59 Nephrology CJASN 59 Interventional Therapies 59 ESTRO 59 Anesthesiologists Annual Meeting 59 Cell Biology ASCB 59 EORTC 59 Cancer EORTC 59 EACTS 59 American Roentgen Ray 59 Rheumatology ACR Annual 59 Intraoperative Surgical Planning 59 Cardiac Techniques 59 SABCS 58 ISTH 58 Cardiovascular Anesthesiologists 58 Gynecologic Cancer Society 58 Neurology Annual Meeting 58 Annual Interscience Conference 58 ICAAC IDSA 58 Cachexia 58 Liver Diseases 58 Oncology Nursing 58 ABCSG 58 Pharmacological Research 58 Breast Cancer Symposium 58 AAN Annual Meeting 58 Arteriosclerosis Thrombosis 58 ADA Scientific Sessions 58 Endoscopic Surgery 58 ORAL Sync 58 congress ECCO 58 AASLD Meeting 58 #nd EORTC NCI 58 AACR symposium 58 Neurology AAN 58 Late Breaker 58 Remote Sensing ISPRS 58 Gynecologic Investigation 58 AACR NCI EORTC 58 Human Brain Mapping 58 ASTRO Annual Meeting 58 Neuropsychopharmacology 57 Reproductive Medicine ASRM 57 Rheumatology 57 EFORT Congress 57 ESCRS 57 Breast Cancer Symposium SABCS 57 Scientific Session 57 AHA Scientific Sessions 57 Brentuximab Vedotin SGN 57 Neurological Surgeons Annual Meeting 57 American Thoracic Society 57 Therapeutic Radiation Oncology 57 EUROGIN 57 Opportunistic Infections CROI 57 Neuroendocrinology 57 Antimicrobial Chemotherapy 57 Transcatheter Cardiovascular Therapeutics 57 Surgical Oncology SSO 57 Biomolecular Sciences SBS 57 AACR Meeting 57 Alzheimer Disease ICAD 57 AACR Annual Meeting 57 Chicago Multidisciplinary Symposium 57 Cancer AACR NCI 57 Gynecologic Oncologists 57 ASBMR 57 Applied Spectroscopy 57 Human Reproduction 57 Lung Cancer IASLC 56 GASTRO 56 Urology EAU Congress 56 Anesthesiologists ASA 56 Investigative Dermatology 56 Outcomes Research ISPOR 56 Scientific Meeting 56 Interventions SCAI 56 Controlled Release 56 ExTRACT TIMI 56 Lung Transplantation 56 ECNP Congress 56 Ocular Pharmacology 56 HUPO 56 Clinical Chemistry AACC 56 Anesthesiologists ASA Annual Meeting 56 Diabetologia 56 Chemotherapy ICAAC Infectious Diseases 56 Targeted Anticancer Therapies 56 dose escalation clinical 56 #nd Annual Meeting 56 Liver Disease AASLD 56 Ophthalmology AAO 56 Annual BIO 56 Annual ICAAC 56 Clinical Pathology ASCP 56 Bipolar Disorders 56 America HFSA 56 Integrative Oncology 56 Cimzia ® certolizumab pegol 56 Heart Rhythm 56 Intensive Care Medicine 56 AAPS Annual Meeting 56 Gastrointestinal Endoscopy ASGE 56 HIV Pathogenesis 56 Breast Surgeons 56 Medicine SIIM 56 Investigative Pathology 56 #rd Annual CTRC 56 EASD 55 tocilizumab 55 CROI 55 Cardio Thoracic Surgery 55 Antiviral Research 55 Neck Cancer 55 Echocardiography ASE 55 metastatic castration resistant 55 AASLD 55 System Pharmacists ASHP 55 Haemostasis 55 assessing T DM1 55 Certican 55 BioEquity Europe 55 Thoracic Oncology 55 Endovascular Therapy 55 Genital Infection 55 abstracts summarizing 55 Cervical Pathology 55 Solorel TM 55 Gynecologic Oncologists SGO 55 Endovascular Therapy ISET 55 Minimally Invasive Spine Surgery 55 Diabetic Macular Edema 55 Cancer Immunotherapy 55 Neck Surgery Foundation 55 Conference EBCC 55 CLARITY study 55 Angiology 55 Minimally Invasive Cardiothoracic Surgery 55 Pirfenidone 55 histone deacetylase HDAC inhibitor 55 CONBRIZA 55 Midyear Clinical Meeting 55 Gastroenterology ACG Annual 55 LSE ASM 54 Vascular Annual Meeting 54 Metabolic Disorders 54 Nephrology JASN 54 Novalis Circle 54 AAO HNSF Annual Meeting 54 DIA EuroMeeting 54 Vascular Biology ATVB 54 PROVENGE sipuleucel T 54 EAACI 54 CLL8 54 Remote Sensing ASPRS 54 Endoscopic Surgeons 54 Cardiology 54 Pneumology 54 Neoplasia 54 SCHWARZ PHARMA 54 Liver Disease 54 Optical Communication ECOC 54 orphan medicinal product 54 Endocrine Society #st 54 Ophthalmology ARVO 54 Hematological Malignancies 54 Targeted Therapies 54 Deutsches Herzzentrum 54 Clinical Trial Results 54 RAI Exhibition 54 Neuro Oncology 54 Annual EuroMeeting 54 Refractive Surgery ASCRS 54 Cardiovascular Angiography 54 Interventional Radiological Society 54 ARVO 54 PreCISe 54 Phase 2a Study 54 AAPOS 54 CTRC AACR 54 Anaesthesiologists 54 Chronic Lymphocytic Leukemia 54 Inflammatory Bowel Diseases 54 Opportunistic Infections 54 Mario Negri 54 Randomized Phase 54 sorafenib tablets 54 Cell Therapy 54 Clinical Endocrinologists AACE 54 Safinamide 54 Prostate Cancer Symposium 54 ASGT 54 Arch Surg 54 AACR 54 Paediatric Endocrinology 54 Autoimmunity 54 #th Interscience Conference 53 Translational Oncology 53 BCIRG 53 Oral Implantologists 53 RECORD1 53 Chronic Lymphocytic Leukemia CLL 53 Immunology Annual Meeting 53 OARSI 53 Oral Fingolimod 53 Thoracic Surgeons STS 53 Combination REOLYSIN R 53 Digestive Diseases Week 53 Recurrent Chest Wall 53 Announces Poster Presentations 53 pulmonary arterial hypertension PAH 53 Biodefense Vaccines 53 interferon gamma 1b 53 Cardiovascular Interventions 53 DIA Annual Meeting 53 Multilateral Initiative 53 NASDAQ CXSP announced 53 Advanced Renal Cell 53 Randomized Study 53 USpella 53 evaluating tivozanib 53 Interscience Conference 53 Lysosomal Disease Network 53 Hsp# Inhibitor 53 AIR2 Trial 53 ASCO Genitourinary Cancers Symposium 53 Maternal Fetal Medicine SMFM 53 cetuximab Erbitux 53 Clinical Chemistry 53 TORISEL 53 Gastrointestinal Oncology 53 Sanofi aventis EURONEXT SAN 53 Aesthetic Plastic Surgery ISAPS 53 orally inhaled migraine 53 Selective Cardiac Myosin 53 & Immunology AAAAI 53 CombAT 53 Nephrology 53 Molecular Medicine Tri 53 Long Awaited Reality 53 ACUITY trial 53 Hematological 53 Clinical Oncologists ASCO 53 Gene Therapy Advisory 53 GTCbio 53 INSPIRE Trial Phase III 53 Preventive Oncology 53 & OTO EXPO 53 Retroviruses 53 Oral Presentation 53 Addex Pharmaceuticals SIX ADXN 53 Malignant Mesothelioma 53 GTCbio 3rd 53 ASCO Breast Cancer 53 randomized Phase III 53 Cardiology Scientific Sessions 53 ELACYT 52 Diabet Med 52 AVERROES 52 CIMZIA TM certolizumab pegol 52 Val HeFT 52 Gastrointestinal Endoscopy 52 Refractive Surgeons 52 FDA Oncologic Drugs 52 AACR Frontiers 52 paroxysmal nocturnal hemoglobinuria PNH 52 Lung Cancer WCLC 52 Systemic Lupus Erythematosus 52 Movement Disorders 52 Female Urology 52 RANK Ligand inhibitor 52 ongoing Phase 1b 52 CHEST 52 Molecular Biology Organization 52 FOLOTYN ® 52 CLARITY TIMI 52 HIMSS Healthcare 52 Endocrinology 52 BiTE R 52 Rheumatology Annual 52 Neuroendocrine 52 J Clin Oncol 52 TORISEL TM 52 Vascular Surgery SVS 52 Environ Health Perspect 52 Medicine AAPM 52 Pediatric Academic Societies PAS 52 pan HDAC inhibitor 52 Poster Presentation 52 BioPartnering Europe 52 oral FTY# 52 Physiological Sciences 52 teriflunomide 52 Neuromuscular Diseases 52 International Neuropsychological Society 52 AACR Symposium 52 dei Tumori 52 FIP Pharmaceutical 52 Lung Transplantation ISHLT 52 SNT MC# 52 PROSTVAC TM 52 Cloretazine ® 52 SUCCEED trial 52 CIRSE 52 Interventional Radiology 52 Aryplase 52 Experimental Medicine 52 Neurological Surgeons 52 Safety Tolerability 52 AACR IASLC Joint 52 Vascular Medicine 52 J Clin Endocrinol Metab 52 AA Amyloidosis 52 ASCO GU 52 Photocure ASA 52 axitinib 52 lexidronam injection 52 Clinical Virology Symposium 52 Colposcopy 52 Interventional Pain Physicians ASIPP 52 Systemic Sclerosis 52 th Interscience Conference 52 Abstract Accepted 52 Hexvix 52 Endoscopic Surgeons SAGES 52 Nexavar sorafenib 52 ASCO 52 Interventional Oncology 52 Heart Failure Society 52 NanoEurope 52 Respiratory Medicine 52 Transplantation AST 52 transthyretin TTR mediated amyloidosis 52 Femara letrozole 52 IL# PE#QQR 52 registrational Phase 52 Randomized Phase II 52 ACR ARHP 52 Temsirolimus 52 Gastroenterology ACG 52 mCRC 52 RoACTEMRA 52 Preclinical Data 52 ALS MND 52 Phase III AFFIRM 52 RIO Lipids 52 thetreatment 52 Canaccord Adams Hepatitis C 52 vascular disrupting agent 52 EVEREST II 52 Amrubicin 52 VEITHsymposium 52 Infectious Diseases ESCMID 52 Ixempra 51 Trandolapril 51 Biomolecular Sciences 51 Toxicology SOT 51 Arch Neurol 51 severe hypercholesterolemia 51 Solid Tumors 51 YONDELIS 51 Hernia Society 51 Esbriet ® 51 ASMS Conference 51 Severe Sepsis 51 Firdapse TM amifampridine phosphate 51 Tanespimycin 51 Cardiology ACC 51 DU #b 51 Colorectal Cancer CRC 51 EURIDIS 51 Haematology 51 alvimopan 51 Belimumab 51 Endocrine Society Annual Meeting 51 Nordic ACTI 51 Hygiene ASTMH 51 recurrent GBM 51 Drugs Affecting Lipid 51 CTI Nasdaq 51 Prolongs Survival 51 Experimental Biology FASEB 51 Phacilitate Vaccine Forum 51 Cancer Patients Treated 51 Am J Epidemiol 51 Overactive Bladder OAB 51 Headache Society 51 pertuzumab 51 II Clinical Trial 51 developer Antisoma plc 51 Mantle Cell Lymphoma 51 Initiates Phase III 51 Retrovirus Conference 51 relapsing multiple sclerosis 51 Gynecologic Oncology Group 51 Cardiometabolic 51 Transplant Surgeons ASTS 51 Ocular Inflammation 51 BIOCOM Investor Conference 51 Gynecological Oncology 51 Cardiovascular Disease Epidemiology 51 EMBO J. 51 Prostate AdenoCarcinoma Treatment 51 Multicenter 51 Cancer Therapeutic 51 ELIQUIS 51 HCV Protease Inhibitor 51 relapsing remitting multiple sclerosis 51 Relapsed Multiple Myeloma 51 ® cetuximab 51 Experimental Biology EB 51 Annual BioPartnering Europe 51 metastatic colorectal cancer 51 sunitinib Sutent 51 rivaroxaban Xarelto 51 Avastin bevacizumab 51 Edge STudy 51 Phase III Clinical Trial 51 Ambrisentan 51 DASISION 51 recurrent malignant glioma 51 Hodgkin lymphoma HL 51 Oncologic Drugs Advisory 51 Castration Resistant Prostate Cancer 51 SCAI Annual 51 Interventional Radiologists 51 standard chemotherapy regimen 51 Acquired Immune Deficiency Syndromes 51 CALGB # [002] 51 Autoimmune Diseases 51 HCV SPRINT 51 Cancer Therapeutics 51 ENLIGHT 51 IASLC 51 Lambert Eaton Myasthenic 51 Neuromodulation Society 51 Intervention Effectiveness 51 RLA festivities 51 Neurochemistry 51 Stent Thrombosis 51 BIO InvestorForum 51 HyQ 51 number NCT# ClinicalTrials.gov 51 ENDO 51 TASKi2 51 Exploration Geophysicists SEG 51 ankylosing spondylitis AS 51 Chaos Communication 51 J Am Coll 51 Multicenter Study 51 Cytology 51 Oligonucleotide Therapeutics Society 51 AAGL 51 Annual Meeting 51 Pulmonary Arterial Hypertension 51 ALN TTR 51 Nutrition ASN 51 Cell Transplant 51 relapsing remitting MS RRMS 51 Marketing Authorization Application 51 IEEE Electron Devices 51 iSBTc 51 Vandetanib 51 Clinical Pharmacology 51 Osseointegration 51 sNDA submission 51 Medical Mycology 51 Gynecological Cancer 51 ELSO 51 Artificial Organs 51 ARCOXIA 51 American Gastrointestinal Endoscopic 51 Aesthetic Mesotherapy 51 Psychoneuroendocrinology 51 Thoracic Surgeons 50 Nuclear Cardiology 50 depsipeptide 50 Dr. Pingpank 50 Arch Intern Med 50 Vacuum Coaters 50 anti arrhythmic drug 50 trabectedin 50 Syndrome LEMS 50 Hormone Refractory Prostate Cancer 50 Gemzar ® 50 Ranolazine 50 NASDAQ SLXP today 50 Spine Arthroplasty Society 50 #:#-# [031] 50 Communications ECOC 50 Human Medicinal Products 50 Carfilzomib 50 Am J Pathol 50 ACC.# 50 Related Viruses 50 Bazedoxifene 50 Cardiovascular Computed Tomography 50 FASEB J. 50 Colorectal Cancer Screening 50 metaglidasen 50 EU PVSEC 50 Ovarian PLCO Cancer 50 Respiratory Care AARC 50 Cambridge Healthtech Institute 50 HORIZONS AMI 50 Hedgehog Pathway Inhibitor 50 Cancer Epidemiol Biomarkers Prev 50 HCV NS5B polymerase 50 SCCHN 50 Neurological Surgeons AANS 50 ACR ARHP Annual 50 PRNewswire FirstCall Tercica 50 Natalizumab 50 RCW Breast Cancer 50 Professional Sleep Societies 50 Microplasmin 50 Experimental Therapeutics 50 Healthcare Publication Editors 50 CALGB 50 Influenza Vaccines 50 Multiple Myeloma 50 Phase 2b Clinical Trial 50 Poster Discussion 50 Bariatric Physicians ASBP 50 Torisel temsirolimus 50 Molecular Pathology 50 RE LY 50 Neupro R 50 Nasdaq REGN 50 Peptide Symposium 50 Presents Positive 50 Medicinal Products EMEA 50 Metastatic Colorectal Cancer 50 Myelodysplastic Syndromes 50 Fondaparinux 50 YONDELIS R 50 IMPAKT Breast Cancer 50 KRN# 50 Therapeutic Targets 50 SWX RO SWX ROG 50 Neurosurgical Societies 50 Cardiovascular Magnetic Resonance 50 antibody blinatumomab MT#/MEDI-# 50 Malaria MIM 50 Poster Presentations 50 comparing alemtuzumab 50 Cardiovascular Therapeutics 50 FOCIS 50 dual endothelin receptor antagonist 50 Otology Rhinology 50 LUX Lung 50 Cutaneous T 50 Addiction Medicine ASAM 50 Surgeons ACS 50 sorafenib Nexavar 50 ® DDW 50 Geochimica et Cosmochimica Acta 50 Paediatric Neurology 50 CYT# potent vascular disrupting 50 Mepact 50 Continence Society 50 brivaracetam 50 Orphan Medicinal Products 50 PEGylated interferon beta 1a 50 Hand ASSH 50 Inc. Nasdaq ATHX 50 ADVANCE PD 50 relapsed refractory multiple myeloma 50 J Natl Cancer Inst 50 Prospective Randomized 50 Nexavar tablets 50 Arpida Ltd. 50 Aggressive Reduction 50 ENDEAVOR III 50 Onrigin 50 Lancet Oncology 50 HuMax EGFr 50 radezolid 50 Atypical Hemolytic Uremic Syndrome 50 Oak Brook Ill. RSNA.org 50 Meets Primary Endpoint 50 Phase 2b trial 50 Phase Ib II 50 Cardiac Pacing 50 CRLX# 50 CAPRISA 50 Afinitor ® 50 Molecular Cancer 50 oral rivaroxaban 50 Complicated Skin 50 Active Biotech NASDAQ OMX 50 BRIM3 50 Lung Cancer 50 International Verapamil SR 50 entitled Synergistic 50 Plastic Surgeons ASPS Plastic 50 Toxicogenomics 50 Prospective Multicenter 50 Association Executives ASAE 50 EXPAREL ™ 50 NCCTG N# 50 Surgical Oncology 50 SUTENT ® 50 Presents Preclinical 50 Investigational Drug 50 Proc Am Soc 50 Romiplostim 50 HFSA Annual 50 Clinical Oncology JCO 50 entinostat 50 novel VDA molecule 50 Rhinology 50 Deforolimus 50 galiximab 50 Thoraxcenter Erasmus University 50 Cellular Therapy 50 Oral Presentations 50 Liver Cancer 50 Selective Cardiac Myosin Activator 50 CNTO 49 Dermatologic Surgery ASDS 49 FOLFOX6 chemotherapy regimen 49 phase IIb study 49 MEK inhibitor 49 journal Antimicrobial Agents 49 IRESSA 49 satraplatin Phase 49 CTAP# Capsules 49 Advanced Solid Tumors 49 Pharmacoepidemiology 49 Annual CTRC AACR 49 JAIDS 49 mitogen activated ERK kinase 49 CARE HF 49 America RSNA 49 Molecular Diagnostics 49 Geriatric Oncology 49 b3c newswire 49 mCRC patients 49 Application MAA 49 ProSavin 49 TEMODAL 49 Investigational Compound 49 Recordati SpA 49 BR.# 49 Ophthalmic Drugs Advisory 49 Endocrine Society #nd 49 Bariatric Surgery ASBS 49 Novel Therapeutics 49 essential thrombocythemia ET 49 Atacand 49 IMPACT IMmunotherapy 49 Jupiter Tequesta Orchid 49 Experimental Neurology 49 Phase 2a trial 49 Romidepsin 49 ASCRS 49 GSMA Mobile World 49 abatacept 49 Science Translational Medicine 49 ErbB2 positive 49 AABB Annual Meeting 49 ECOC 49 MAA submission 49 Oral Implantology 49 Phase #/#a trial 49 Urologic Oncology SUO 49 Molecular Medicine MDC 49 Malignant Melanoma 49 Phase 2a clinical 49 Rheumatism EULAR 49 Ann Intern Med 49 Bone Marrow Transplantation 49 Torisel 49 Clinical Neurophysiology 49 novel histone deacetylase 49 SMi 49 Proteome Research 49 Anticancer Drug 49 cediranib 49 System Pharmacists Midyear 49 Phase 1b trial 49 metastatic renal cell carcinoma 49 Pediatric Otolaryngology 49 Postgraduate Course 49 Healthcare Epidemiology 49 Cardiovascular Intervention 49 Immunology AAAAI 49 Rivaroxaban 49 Dasatinib 49 ESHO 49 investigational antiplatelet agent 49 multiple myeloma MM 49 Alpharadin 49 glucocorticoid induced osteoporosis 49 Dtsch Arztebl Int 49 ABSORB 49 Phase Ib study 49 metastatic hormone refractory 49 bazedoxifene conjugated estrogens 49 coronary stent merged 49 Nasdaq ALXN 49 Br J Cancer 49 th Annual Interscience 49 riociguat 49 Marrow Transplantation 49 Diabetology 49 ASTEROID 49 APPRAISE 49 Biomedical Optics 49 Pulmonary Hypertension 49 Nasdaq GNTA 49 phase IIa clinical 49 Aesthetic Plastic Surgery ASAPS 49 journal Diabetologia 49 Br J Haematol 49 Yondelis 49 Removab 49 Vertex telaprevir 49 Receives Positive Opinion 49 Tasigna nilotinib 49 bazedoxifene 49 Zarnestra 49 Respiratory Disorders 49 FTY# 49 Cardiovascular Diseases 49 Dermatological 49 prostate cancer HRPC 49 acute PAO 49 Hematologic Malignancies 49 chemotherapy gemcitabine 49 Forsteo 49 Chronic Hepatitis C 49 Cardiovascular Computed Tomography SCCT 49 Societe Internationale 49 Innate Immunity 49 SAEM Annual Meeting 49 EchoCRT 49 Metastatic Melanoma 49 SmPC 49 Phase III Trial 49 Aclasta 49 Receives Orphan Drug Designation 49 www.aacr.org 49 Gynecological Oncologists 49 Neuropharmacology 49 journal Hepatology 49 CUSTOM II 49 Dabigatran 49 IRX 2 49 Folfox 49 MTT S 49 Nivestim 49 Molecular Pathology AMP 49 Immunogenetics 49 Ann Oncol 49 JAK2 Inhibitor 49 ABRF 49 Orphan Drug status 49 Stroke Prevention 49 acute coronary syndromes ACS 49 Erbitux cetuximab 49 Metabolic Drugs Advisory 49 Clin Chem 49 Patient Outcomes 49 Phase III ALLEGRO 49 Regional Anesthesia 49 Medicine ISMRM 49 Marine Mammalogy 49 Information Display SID 49 Outcomes Research 49 fosbretabulin 49 eyeforpharma 49 forodesine 49 Experimental Biology 49 Antiviral Drugs Advisory 49 Respiratory Viral Infections 49 Cancer Res 49 Anthracycline 49 adult chronic ITP 49 Namenda Memantine HCl 49 mRCC 49 QNEXA 49 Onbrez Breezhaler 49 Fondazione IRCCS Istituto Nazionale 49 Pediatric Oncology Branch 49 UZ Brussel 49 Bladder Cancer 49 Acute Heart Failure 49 arthritis PsA 49 ILLUMINATE 49 OMP designation 49 hormone refractory metastatic prostate 49 Nexavar ® 49 Pediatric Academic Societies 49 MEDICA 49 HuMax CD4 49 Marketing Authorisation Application 49 Interventional Radiology interventional radiologisiceberg lettuces 49 rheumatic diseases 49 enzastaurin 49 Taxotere ® 49 Everolimus 49 PNP inhibitor 49 Radiologic Technologists ASRT 49 Menopause Society NAMS 49 Receives Marketing Authorization 49 Orphan Diseases 49 Bucindolol 49 includes Dideco CarboMedics 49 Echocardiography 49 neratinib 49 hyperphenylalaninemia HPA due 49 Herceptin trastuzumab 49 Arzerra ofatumumab 49 fidaxomicin 49 Hepatitis C Virus 49 Eur Respir J 49 Newly Diagnosed Multiple Myeloma 48 metastatic HRPC 48 Completes Patient Enrollment 48 AVADO 48 Telavancin 48 Firdapse ™ amifampridine phosphate 48 Acute Ischemic Stroke 48 Phase Ib clinical trials 48 orphan designation 48 Biomolecular Screening 48 Gynaecological Oncology 48 LBH# 48 Patients Treated With 48 Molecular Biology Organization EMBO 48 worsening thrombocytopenia 48 Arterial Hypertension 48 Phase #b/#a clinical 48 Cochrane Hepato Biliary 48 Telmisartan 48 Molecular Origins 48 rilonacept 48 evaluating REVLIMID 48 Breaking Clinical Trials 48 Orthopedic Surgeons AAOS 48 Medical Research Katholic 48 Kongresshaus 48 Soft Tissue Sarcoma 48 Sutent sunitinib malate 48 iclaprim 48 journal Ophthalmology 48 Thoraxcenter 48 Clinical Efficacy 48 MorphoSys AG FSE MOR 48 ASCO abstract 48 Cancer Immunology Immunotherapy

Back to home page